228 related articles for article (PubMed ID: 22865898)
1. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
Ardawi MS; Rouzi AA; Qari MH
J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
[TBL] [Abstract][Full Text] [Related]
2. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
3. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
4. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
Amrein K; Amrein S; Drexler C; Dimai HP; Dobnig H; Pfeifer K; Tomaschitz A; Pieber TR; Fahrleitner-Pammer A
J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.
Adami S; Zivelonghi A; Braga V; Fracassi E; Gatti D; Rossini M; Ulivieri FM; Viapiana O
Bone; 2010 Jan; 46(1):244-7. PubMed ID: 19853071
[TBL] [Abstract][Full Text] [Related]
8. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic osteoporosis in premenopausal women.
Rubin MR; Schussheim DH; Kulak CA; Kurland ES; Rosen CJ; Bilezikian JP; Shane E
Osteoporos Int; 2005 May; 16(5):526-33. PubMed ID: 15300364
[TBL] [Abstract][Full Text] [Related]
10. Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia.
Wild J; Pateisky P; Küssel L; Huf W; Ott J; Haslinger P; Knöfler M; Zeisler H
Hypertens Pregnancy; 2014 Aug; 33(3):333-40. PubMed ID: 24568269
[TBL] [Abstract][Full Text] [Related]
11. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
[TBL] [Abstract][Full Text] [Related]
12. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.
Rucker D; Ezzat S; Diamandi A; Khosravi J; Hanley DA
Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965
[TBL] [Abstract][Full Text] [Related]
13. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
[TBL] [Abstract][Full Text] [Related]
14. Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study.
Moriwaki K; Matsumoto H; Tanishima S; Tanimura C; Osaki M; Nagashima H; Hagino H
BMC Musculoskelet Disord; 2019 Jun; 20(1):276. PubMed ID: 31164134
[TBL] [Abstract][Full Text] [Related]
15. Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.
Morabito N; Catalano A; Gaudio A; Morini E; Bruno LM; Basile G; Tsiantouli E; Bellone F; Agostino RM; Piraino B; La Rosa MA; Salpietro C; Lasco A
J Bone Miner Metab; 2016 Sep; 34(5):540-6. PubMed ID: 26204844
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin levels and changes in bone metabolism after bariatric surgery.
Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
[TBL] [Abstract][Full Text] [Related]
17. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
[TBL] [Abstract][Full Text] [Related]
18. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
[TBL] [Abstract][Full Text] [Related]
19. Gender-Specific Associations of Serum Insulin-Like Growth Factor-1 With Bone Health and Fractures in Older Persons.
van Varsseveld NC; Sohl E; Drent ML; Lips P
J Clin Endocrinol Metab; 2015 Nov; 100(11):4272-81. PubMed ID: 26323023
[TBL] [Abstract][Full Text] [Related]
20. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
Gaudio A; Pennisi P; Bratengeier C; Torrisi V; Lindner B; Mangiafico RA; Pulvirenti I; Hawa G; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2010 May; 95(5):2248-53. PubMed ID: 20305005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
